Enrico Zanalda

1.1k total citations
20 papers, 467 citations indexed

About

Enrico Zanalda is a scholar working on Philosophy, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, Enrico Zanalda has authored 20 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Philosophy, 5 papers in Psychiatry and Mental health and 4 papers in Pharmacology. Recurrent topics in Enrico Zanalda's work include Mental Health and Psychiatry (5 papers), Treatment of Major Depression (4 papers) and Psychosomatic Disorders and Their Treatments (3 papers). Enrico Zanalda is often cited by papers focused on Mental Health and Psychiatry (5 papers), Treatment of Major Depression (4 papers) and Psychosomatic Disorders and Their Treatments (3 papers). Enrico Zanalda collaborates with scholars based in Italy, Canada and United Kingdom. Enrico Zanalda's co-authors include Paola Rocca, L. Ravizza, Filippo Bogetto, Carola Eva, Massimo Tusconi, Giuseppe Rocca, Bernardo Carpiniello, Guido Di Sciascio, Giuseppe Maina and P. Ferrero and has published in prestigious journals such as Biological Psychiatry, Journal of Affective Disorders and Schizophrenia Research.

In The Last Decade

Enrico Zanalda

19 papers receiving 454 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Enrico Zanalda Italy 11 166 165 140 110 78 20 467
Meridith A. Rankin United States 6 185 1.1× 184 1.1× 312 2.2× 196 1.8× 112 1.4× 6 673
Jerónimo Saíz Spain 10 250 1.5× 117 0.7× 149 1.1× 117 1.1× 41 0.5× 20 486
Pablo Romero‐Sanchiz Spain 15 137 0.8× 109 0.7× 44 0.3× 101 0.9× 85 1.1× 37 543
Maja Bajs Croatia 6 110 0.7× 160 1.0× 128 0.9× 157 1.4× 37 0.5× 6 452
Charli Randolph United States 3 137 0.8× 71 0.4× 105 0.8× 161 1.5× 41 0.5× 5 392
Yasuya Nakato Japan 11 149 0.9× 59 0.4× 105 0.8× 60 0.5× 92 1.2× 17 420
M. Ansseau Belgium 11 142 0.9× 114 0.7× 104 0.7× 78 0.7× 66 0.8× 45 386
Deborah S. Cowley United States 9 165 1.0× 191 1.2× 92 0.7× 43 0.4× 76 1.0× 10 414
Mary Ann Knesevich United States 9 122 0.7× 85 0.5× 261 1.9× 77 0.7× 61 0.8× 13 576
Alexandra B. Whitworth Austria 13 212 1.3× 63 0.4× 273 1.9× 68 0.6× 43 0.6× 17 633

Countries citing papers authored by Enrico Zanalda

Since Specialization
Citations

This map shows the geographic impact of Enrico Zanalda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enrico Zanalda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enrico Zanalda more than expected).

Fields of papers citing papers by Enrico Zanalda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Enrico Zanalda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enrico Zanalda. The network helps show where Enrico Zanalda may publish in the future.

Co-authorship network of co-authors of Enrico Zanalda

This figure shows the co-authorship network connecting the top 25 collaborators of Enrico Zanalda. A scholar is included among the top collaborators of Enrico Zanalda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Enrico Zanalda. Enrico Zanalda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lasalvia, Antonio, Mirta Fiorio, Enrico Zanalda, et al.. (2023). Psychiatrists’ attitudes towards functional neurological disorders: results from a national survey. Frontiers in Psychiatry. 14. 1216756–1216756. 5 indexed citations
2.
Sangiorgi, Diego, et al.. (2021). Healthcare Resource Consumption and Related Costs of Patients Estimated with Treatment-Resistant Depression in Italy. ClinicoEconomics and Outcomes Research. Volume 13. 629–635. 5 indexed citations
3.
Montemagni, Cristiana, et al.. (2021). Effects of Cognitive Remediation on Cognition, Metacognition, and Social Cognition in Patients With Schizophrenia. Frontiers in Psychiatry. 12. 19 indexed citations
4.
Lasalvia, Antonio, Antonio Vita, Antonello Bellomo, et al.. (2020). Renaming schizophrenia? A survey among psychiatrists, mental health service users and family members in Italy. Schizophrenia Research. 228. 502–509. 15 indexed citations
5.
Carpiniello, Bernardo, et al.. (2020). Psychiatry during the Covid-19 pandemic: a survey on mental health departments in Italy. BMC Psychiatry. 20(1). 593–593. 46 indexed citations
6.
Nivoli, Alessandra, et al.. (2020). Linee guida in psichiatria: criticità cliniche e forensi. Rivista di psichiatria. 55(6). 40–46. 1 indexed citations
7.
Sangiorgi, Diego, et al.. (2020). Assessment of Patients Affected by Treatment-Resistant Depression: Findings from a Real-World Study in Italy. Cineca Institutional Research Information System (Tor Vergata University). 4(3). 6 indexed citations
8.
Montemagni, Cristiana, et al.. (2019). Cognitive deficits and psychosocial functioning in schizophrenia: role of computer-assisted cognitive remediation. Institutional Research Information System University of Turin (University of Turin). 5. 1–9. 1 indexed citations
11.
Albert, Umberto, et al.. (2015). Manuale di Psichiatria. 1–1253. 3 indexed citations
12.
Munizza, Carmine, Alessandro Coppo, Barbara D’Avanzo, et al.. (2011). [Prevention of depression and suicide. Intervention program integrated with the involvement of general physicians].. PubMed. 19(3 Suppl). VII–XIII, 1. 2 indexed citations
13.
Rocca, Paola, et al.. (2003). Predictors of psychiatric disorders in liver transplantation candidates: Logistic regression models. Liver Transplantation. 9(7). 721–726. 33 indexed citations
14.
Rocca, Paola, Carola Eva, Livio Marchiaro, et al.. (2002). Decrease of the D4 dopamine receptor messenger RNA expression in lymphocytes from patients with major depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 26(6). 1155–1160. 45 indexed citations
15.
Rocca, Paola, et al.. (2002). A comparison of paroxetine and amisulpride in the treatment of dysthymic disorder. Journal of Affective Disorders. 70(3). 313–317. 41 indexed citations
16.
Rocca, Paola, et al.. (1998). Peripheral benzodiazepine receptor messenger RNA is decreased in lymphocytes of generalized anxiety disorder patients. Biological Psychiatry. 43(10). 767–773. 39 indexed citations
17.
Rocca, Paola, et al.. (1997). Paroxetine efficacy in the treatment of generalized anxiety disorder. Acta Psychiatrica Scandinavica. 95(5). 444–450. 133 indexed citations
18.
Zanalda, Enrico, et al.. (1997). Effects of clozapine on avolition-apathy and anhedonia-asociality in schizophrenic patients. Biological Psychiatry. 42(1). 181S–181S. 1 indexed citations
19.
Ravizza, L., Filippo Bogetto, & Enrico Zanalda. (1993). Psychiatry and Advanced Technologies.
20.
Rocca, Paola, P. Ferrero, Enrico Zanalda, et al.. (1991). Peripheral‐type benzodiazepine receptors in anxiety disorders. Acta Psychiatrica Scandinavica. 84(6). 537–544. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026